United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

News provided by

May 15, 2012, 08:27 ET

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

http://www.reportlinker.com/p0862102/United-Kingdom-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

United Kingdom Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the six market categories.- Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devicesmarket. - Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Accuray Incorporated, DePuy, Inc., Stryker Corporation, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the United Kingdom Neurology Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.1 Table of Contents1 Table of Contents 21.1 List of Tables 81.2 List of Figures 102 Introduction 132.1 What is This Report About? 133 Neurology Devices In United Kingdom 143.1 Neurology Devices, Market Segmentation 143.2 Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 153.3 Neurology Devices Market, United Kingdom, Revenue Mix ($m), 2011 173.4 Neurology Devices Market, United Kingdom, Category Contribution (%), 2011 183.5 Neurology Devices, United Kingdom, Company Share (2010-2011) 244 CSF Management In United Kingdom 264.1 CSF Management, Market Segmentation 264.2 CSF Management Market, United Kingdom, Revenue Mix ($m), 2011 274.3 CSF Management Market, United Kingdom, Segment Contribution (%), 2011 284.4 CSF Management Overall Revenue, (2004-2018) 294.5 CSF Management Overall Volume (2004-2018) 334.6 CSF Management Average Price (2004-2018) 354.7 CSF Management Distribution Share (2010-2011) 354.8 CSF Management, United Kingdom, Company Share (2010-2011) 365 Interventional Neurology In United Kingdom 385.1 Interventional Neurology, Market.Segmentation 385.2 Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2011 395.3 Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2011 405.4 Interventional Neurology Overall Revenue, (2004-2018) 415.4.1 Embolic Systems Revenue (2004-2018) 455.4.2 Navigational Systems Revenue (2004-2018) 495.5 Interventional Neurology Overall Volume (2004-2018) 535.5.1 Embolic Systems Volume (2004-2018) 575.5.2 Navigational Systems Volume (2004-2018) 595.6 Interventional Neurology Average Price (2004-2018) 615.7 Interventional Neurology Distribution Share (2010-2011) 625.8 Interventional Neurology, United Kingdom, Company Share (2010-2011) 636 Neurological Diagnostic Equipment In United Kingdom 656.1 Neurological Diagnostic Equipment, Market.Segmentation 656.2 Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2011 666.3 Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2011 676.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018) 686.5 Neurological Diagnostic Equipment Overall Volume (2004-2018) 726.6 Neurological Diagnostic Equipment Average Price (2004-2018) 766.7 Neurological Diagnostic Equipment Distribution Share (2010-2011) 776.8 Neurological Diagnostic Equipment, United Kingdom, Company Share (2010-2011) 787 Neurostimulation Devices In United Kingdom 807.1 Neurostimulation Devices, Market Segmentation 807.2 Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2011 817.3 Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2011 827.4 Neurostimulation Devices Overall Revenue, (2004-2018) 837.5 Neurostimulation Devices Overall Volume (2004-2018) 877.6 Neurostimulation Devices Average Price (2004-2018) 917.7 Neurostimulation Devices Distribution Share (2010-2011) 927.8 Neurostimulation Devices, United Kingdom, Company Share (2010-2011) 938 Neurosurgical Products In United Kingdom 948.1 Neurosurgical Products, Market Segmentation 948.2 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2011 958.3 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2011 968.4 Neurosurgical Products Overall Revenue, (2004-2018) 978.5 Neurosurgical Products Overall Volume (2004-2018) 1018.6 Neurosurgical Products Average Price (2004-2018) 1038.7 Neurosurgical Products Distribution Share (2010-2011) 1038.8 Neurosurgical Products, United Kingdom, Company Share (2010-2011) 1049 Radiosurgery In United Kingdom 1059.1 Radiosurgery, Market Segmentation 1059.2 Radiosurgery Market, United Kingdom, Revenue Mix ($m), 2011 1069.3 Radiosurgery Market, United Kingdom, Segment Contribution (%), 2011 1079.4 Radiosurgery Overall Revenue, (2004-2011) 1089.5 Radiosurgery Overall Volume (2004-2011) 1109.6 Radiosurgery Average Price (2004-2011) 1119.7 Radiosurgery Distribution Share (2010-2011) 1119.8 Radiosurgery, United Kingdom, Company Share (2010-2011) 11210 Overview of Key Companies in United Kingdom Neurology Devices Market 11310.1 Medtronic, Inc. 11310.1.1 Company Overview 11310.1.2 Share in the United Kingdom Neurology Devices Market 11310.2 St. Jude Medical, Inc. 11410.2.1 Company Overview 11410.2.2 Share in the United Kingdom Neurology Devices Market 11410.3 Accuray Incorporated 11510.3.1 Company Overview 11510.3.2 Share in the United Kingdom Neurology Devices Market 11510.4 DePuy, Inc. 11610.4.1 Company Overview 11610.4.2 Share in the United Kingdom Neurology Devices Market 11610.5 Stryker Corporation 11710.5.1 Company Overview 11710.5.2 Share in the United Kingdom Neurology Devices Market 11710.6 B. Braun Melsungen AG 11810.6.1 Company Overview 11810.6.2 Share in the United Kingdom Neurology Devices Market 11810.7 Boston Scientific Corporation 11910.7.1 Company Overview 11910.8 Cyberonics, Inc. 11910.8.1 Company Overview 11910.9 Terumo Corporation 12010.9.1 Company Overview 12010.10 Integra LifeSciences Holdings Corporation 12010.10.1 Company Overview 12010.11 Cadwell Laboratories, Inc. 12010.11.1 Company Overview 12010.12 Natus Medical Incorporated 12110.12.1 Company Overview 12110.13 Micromed S.p.A 12110.13.1 Company Overview 12110.14 Christoph Miethke GmbH & Co. KG 12110.14.1 Company Overview 12110.15 CareFusion Corporation 12210.15.1 Company Overview 12210.16 Nihon Kohden Corporation 12210.16.1 Company Overview 12210.17 KARL STORZ GmbH & Co. KG 12310.17.1 Company Overview 12310.18 Sophysa S.A. 12310.18.1 Company Overview 12310.19 Covidien plc 12310.19.1 Company Overview 12310.20 Elekta AB 12410.20.1 Company Overview 12411 Neurology Devices Market Pipeline Products 12512 Financial Deals Landscape 13112.1 Partnerships 13112.1.1 GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 13113 Recent Developments 13213.1 Government and Public Interest 13213.1.1 Apr 23, 2012: New Technique May Help Severely Damaged Nerves Regrow And Restore Function: University of Sheffield 13213.1.2 Jan 10, 2012: Fusion Plasma Research Helps Neurologists To Hear Above The Noise 13314 Appendix 13514.1 Definitions of Markets Covered in the Report 13614.1.1 Neurology Devices 13614.2 Research Methodology 14014.3 Secondary Research 14014.4 Primary Research 14114.5 Models 14114.6 Forecasts 14214.7 Expert Panels 14214.8 GlobalData Consulting 14214.9 Currency Conversion 14314.10 Contact Us 14314.11 Disclaimer 143

List of Tables

Table 1: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 15Table 2: Neurology Devices Market, United Kingdom, Category Contribution (%), 2011 17Table 3: Neurology Devices, United Kingdom, Cross-Category Analysis, 2004-2018 18Table 4: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20Table 5: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22Table 6: Neurology Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 24Table 7: CSF Management Market, United Kingdom, Segment Contribution (%), 2011 27Table 8: CSF Management, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 29Table 9: CSF Management, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 31Table 10: CSF Management, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 32Table 11: CSF Management, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 33Table 12: CSF Management, United Kingdom, Average Price ($), Historic, 2004-2011 34Table 13: CSF Management, United Kingdom, Average Price ($), Forecast, 2011-2018 34Table 14: CSF Management, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 34Table 15: CSF Management, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 36Table 16: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2011 39Table 17: Interventional Neurology, United Kingdom, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011 41Table 18: Interventional Neurology, United Kingdom, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018 43Table 19: Embolic Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 45Table 20: Embolic Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 47Table 21: Navigational Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49Table 22: Navigational Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 51Table 23: Interventional Neurology, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 53Table 24: Interventional Neurology, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 55Table 25: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 56Table 26: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 57Table 27: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 58Table 28: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 59Table 29: Interventional Neurology, United Kingdom, Average Price ($), Historic, 2004-2011 60Table 30: Interventional Neurology, United Kingdom, Average Price ($), Forecast, 2011-2018 60Table 31: Interventional Neurology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 61Table 32: Interventional Neurology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 63Table 33: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2011 66Table 34: Neurological Diagnostic Equipment, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 68Table 35: Neurological Diagnostic Equipment, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 70Table 36: Neurological Diagnostic Equipment, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 72Table 37: Neurological Diagnostic Equipment, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 74Table 38: Neurological Diagnostic Equipment, United Kingdom, Average Price ($), Historic, 2004-2011 75Table 39: Neurological Diagnostic Equipment, United Kingdom, Average Price ($), Forecast, 2011-2018 75Table 40: Neurological Diagnostic Equipment, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 76Table 41: Neurological Diagnostic Equipment, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 78Table 42: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2011 81Table 43: Neurostimulation Devices, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 83Table 44: Neurostimulation Devices, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 85Table 45: Neurostimulation Devices, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 87Table 46: Neurostimulation Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 89Table 47: Neurostimulation Devices, United Kingdom, Average Price ($), Historic, 2004-2011 90Table 48: Neurostimulation Devices, United Kingdom, Average Price ($), Forecast, 2011-2018 90Table 49: Neurostimulation Devices, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 91Table 50: Neurostimulation Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 92Table 51: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2011 95Table 52: Neurosurgical Products, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 97Table 53: Neurosurgical Products, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 99Table 54: Neurosurgical Products, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 100Table 55: Neurosurgical Products, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 101Table 56: Neurosurgical Products, United Kingdom, Average Price ($), Historic, 2004-2011 102Table 57: Neurosurgical Products, United Kingdom, Average Price ($), Forecast, 2011-2018 102Table 58: Neurosurgical Products, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 102Table 59: Neurosurgical Products, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 103Table 60: Radiosurgery Market, United Kingdom, Segment Contribution (%), 2011 106Table 61: Radiosurgery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 108Table 62: Radiosurgery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 109Table 63: Radiosurgery, United Kingdom, Average Price ($), Historic, 2004-2011 110Table 64: Radiosurgery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 110Table 65: Radiosurgery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 111Table 66: Neurology Devices Market Pipeline Products 124Table 67: GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 130

List of Figures

Figure 1: Neurology Devices, Market Segmentation 13Figure 2: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 14Figure 3: Neurology Devices Market, United Kingdom, Revenue Mix ($m), 2011 16Figure 4: Neurology Devices Market, United Kingdom, Category Contribution (%), 2011 17Figure 5: Neurology Devices, United Kingdom, Cross-Category Analysis, 2004-2018 18Figure 6: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19Figure 7: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21Figure 8: Neurology Devices, United Kingdom, Company Share (%), 2011 23Figure 9: CSF Management, Market Segmentation 25Figure 10: CSF Management Market, United Kingdom, Revenue Mix ($m), 2011 26Figure 11: CSF Management Market, United Kingdom, Segment Contribution (%), 2011 27Figure 12: CSF Management, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 28Figure 13: CSF Management, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 30Figure 14: CSF Management, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 32Figure 15: CSF Management, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 33Figure 16: CSF Management, United Kingdom, Company Share (%), 2011 35Figure 17: Interventional Neurology, Market Segmentation 37Figure 18: Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2011 38Figure 19: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2011 39Figure 20: Interventional Neurology, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 40Figure 21: Interventional Neurology, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 42Figure 22: Embolic Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 44Figure 23: Embolic Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 46Figure 24: Navigational Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 48Figure 25: Navigational Systems, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 50Figure 26: Interventional Neurology, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 52Figure 27: Interventional Neurology, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 54Figure 28: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 56Figure 29: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 57Figure 30: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 58Figure 31: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 59Figure 32: Interventional Neurology, United Kingdom, Company Share (%), 2011 62Figure 33: Neurological Diagnostic Equipment, Market Segmentation 64Figure 34: Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2011 65Figure 35: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2011 66Figure 36: Neurological Diagnostic Equipment, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 67Figure 37: Neurological Diagnostic Equipment, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 69Figure 38: Neurological Diagnostic Equipment, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 71Figure 39: Neurological Diagnostic Equipment, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 73Figure 40: Neurological Diagnostic Equipment, United Kingdom, Company Share (%), 2011 77Figure 41: Neurostimulation Devices, Market Segmentation 79Figure 42: Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2011 80Figure 43: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2011 81Figure 44: Neurostimulation Devices, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 82Figure 45: Neurostimulation Devices, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 84Figure 46: Neurostimulation Devices, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 86Figure 47: Neurostimulation Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 88Figure 48: Neurostimulation Devices, United Kingdom, Company Share (%), 2011 92Figure 49: Neurosurgical Products, Market Segmentation 93Figure 50: Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2011 94Figure 51: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2011 95Figure 52: Neurosurgical Products, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 96Figure 53: Neurosurgical Products, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 98Figure 54: Neurosurgical Products, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 100Figure 55: Neurosurgical Products, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 101Figure 56: Neurosurgical Products, United Kingdom, Company Share (%), 2011 103Figure 57: Radiosurgery, Market Segmentation 104Figure 58: Radiosurgery Market, United Kingdom, Revenue Mix ($m), 2011 105Figure 59: Radiosurgery Market, United Kingdom, Segment Contribution (%), 2011 106Figure 60: Radiosurgery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 107Figure 61: Radiosurgery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 109Figure 62: Radiosurgery, United Kingdom, Company Share (%), 2011 111Figure 63: Medtronic, Inc., Company Share (%),United Kingdom Neurology Devices Market, 2011 112Figure 64: St. Jude Medical, Inc., Company Share (%),United Kingdom Neurology Devices Market, 2011 113Figure 65: Accuray Incorporated, Company Share (%),United Kingdom Neurology Devices Market, 2011 114Figure 66: DePuy, Inc., Company Share (%),United Kingdom Neurology Devices Market, 2011 115Figure 67: Stryker Corporation, Company Share (%),United Kingdom Neurology Devices Market, 2011 116Figure 68: B. Braun Melsungen AG, Company Share (%),United Kingdom Neurology Devices Market, 2011 117